The Technical AnalystExchange: SHZ Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
PKU HealthCare Corp.,Ltd. Price, Forecast, Insider, Ratings, Fundamentals & Signals
3.72% CNY6.13
America/New_York / 5 mai 2024 @ 23:19
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 3 653.40 mill |
| EPS: | 0.120 |
| P/E: | 51.08 |
| Earnings Date: | N/A |
| SharesOutstanding: | 595.99 mill |
| Avg Daily Volume: | 9.42 mill |
| RATING 2024-04-30 |
|---|
| A- |
| Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Neutral | |
| Return On Equity: | Buy | |
| Return On Asset: | Buy | |
| DE: | Neutral | |
| P/E: | Buy | |
| Price To Book: | Neutral |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 1.43x |
| Company: PE 51.08 | sector: PE 35.84 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 1.12x |
| Company: PE 51.08 | industry: PE 45.57 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
CNY1.960 (-68.03%) CNY-4.17 |
| Date: 2024-05-05 |
| Expected Trading Range (DAY) |
|---|
|
CNY 5.75 - 6.07 ( +/- 2.72%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | CNY6.13 (3.72% ) |
| Volume | 33.12 mill |
| Avg. Vol. | 9.42 mill |
| % of Avg. Vol | 351.54 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For 000788.SZ
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
000788.SZ
PKU HealthCare Corp.,Ltd. researches, develops, manufactures, and sells pharmaceutical products in China. It offers products in various categories, including anti-tumor, neuropsychiatric, cardiovascular, immunosuppressive, antimicrobial, antipyretic and analgesic, digestive system, regulate immunity, oncology, anti-allergic, blood sugar regulation, mental disorder, and blood volume expansion. The company was formerly known as PUK International Hospital Group Southwest Synthetic Pharmaceutical Corp., Ltd. and changed its name to PKU HealthCare Corp., Ltd. in November 2013. PKU HealthCare Corp.,Ltd. was founded in 1965 and is headquartered in Chongqing, China.